Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2D6, CYP3A4 and CYP1A2 and antipsychotics-Reference-Cited by-同舟云学术

Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2D6, CYP3A4 and CYP1A2 and antipsychotics

Published:2023-03-31 Issue: Volume: Page:
ISSN:1018-4813
Container-title:European Journal of Human Genetics
language:en
Short-container-title:Eur J Hum Genet

Author:

Beunk Lianne,Nijenhuis Marga^ORCID,Soree Bianca,de Boer-Veger Nienke J.,Buunk Anne-Marie,Guchelaar Henk Jan,Houwink Elisa J. F.^ORCID,Risselada Arne,Rongen Gerard A. P. J. M.,van Schaik Ron H. N.,Swen Jesse J.^ORCID,Touw Daan^ORCID,van Westrhenen Roos^ORCID,Deneer Vera H. M.,van der Weide Jan

Funder

EC | Horizon 2020 Framework Programme

Royal Dutch Pharmacists Association

Publisher

Springer Science and Business Media LLC

Subject

Genetics (clinical),Genetics

Link

https://www.nature.com/articles/s41431-023-01347-3.pdf

Reference38 articles.

1. Swen JJ, Huizinga TW, Gelderblom H, de Vries EGE, Assendelft WJJ, Kirchheiner J, et al. Translating pharmacogenomics: challenges on the road to the clinic. PLoS Med. 2007;4:e209.

2. van Westrhenen R, Aitchison KJ, Ingelman-Sundberg M, Jukić MM. Pharmacogenomics of antidepressant and antipsychotic treatment: How far have we got and where are we going? Front Psychiatry. 2020;11:94.